1. Home
  2. ADAG vs SIEB Comparison

ADAG vs SIEB Comparison

Compare ADAG & SIEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADAG
  • SIEB
  • Stock Information
  • Founded
  • ADAG 2011
  • SIEB 1886
  • Country
  • ADAG China
  • SIEB United States
  • Employees
  • ADAG N/A
  • SIEB N/A
  • Industry
  • ADAG Biotechnology: Pharmaceutical Preparations
  • SIEB Investment Bankers/Brokers/Service
  • Sector
  • ADAG Health Care
  • SIEB Finance
  • Exchange
  • ADAG Nasdaq
  • SIEB Nasdaq
  • Market Cap
  • ADAG 85.9M
  • SIEB 94.9M
  • IPO Year
  • ADAG 2021
  • SIEB N/A
  • Fundamental
  • Price
  • ADAG $1.84
  • SIEB $3.01
  • Analyst Decision
  • ADAG Strong Buy
  • SIEB
  • Analyst Count
  • ADAG 1
  • SIEB 0
  • Target Price
  • ADAG $5.00
  • SIEB N/A
  • AVG Volume (30 Days)
  • ADAG 24.0K
  • SIEB 23.7K
  • Earning Date
  • ADAG 03-09-2025
  • SIEB 11-12-2024
  • Dividend Yield
  • ADAG N/A
  • SIEB N/A
  • EPS Growth
  • ADAG N/A
  • SIEB 61.43
  • EPS
  • ADAG N/A
  • SIEB 0.27
  • Revenue
  • ADAG $815,746.00
  • SIEB $83,357,000.00
  • Revenue This Year
  • ADAG N/A
  • SIEB N/A
  • Revenue Next Year
  • ADAG $2.70
  • SIEB N/A
  • P/E Ratio
  • ADAG N/A
  • SIEB $11.18
  • Revenue Growth
  • ADAG N/A
  • SIEB 27.81
  • 52 Week Low
  • ADAG $1.74
  • SIEB $1.41
  • 52 Week High
  • ADAG $4.38
  • SIEB $3.34
  • Technical
  • Relative Strength Index (RSI)
  • ADAG 40.33
  • SIEB 50.35
  • Support Level
  • ADAG $1.76
  • SIEB $2.91
  • Resistance Level
  • ADAG $2.07
  • SIEB $3.34
  • Average True Range (ATR)
  • ADAG 0.14
  • SIEB 0.17
  • MACD
  • ADAG -0.00
  • SIEB -0.03
  • Stochastic Oscillator
  • ADAG 23.53
  • SIEB 43.10

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

About SIEB Siebert Financial Corp.

Siebert Financial Corp is a holding company. It conducts retail discount brokerage business through its wholly-owned subsidiary. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.

Share on Social Networks: